Which hedge funds own ARCT? ARCTURUS THERAPEUTICS HLDGS, Q2 2026 13F holders
HealthcareBiotechnologyFollow
16 tracked hedge funds disclosed a position in ARCT (ARCTURUS THERAPEUTICS HLDGS) in their Q2 2026 13F filings, worth $21.0m in total. The largest holder by portfolio weight is Gsa Capital Partners LLP at 0.0% of its book. 4 opened a new position this quarter: Y-Intercept (Hong Kong) Ltd, Schonfeld Strategic Advisors LLC, Walleye Capital LLC, Marshall Wace, LLP. 1 exited: ADAR1 Capital Management, LLC.
16
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
4
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
1
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$1.1m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$116k
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$21.0m
Combined value
Sum of the holders' reported positions in the security.
1.3%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.